Guest guest Posted February 11, 2012 Report Share Posted February 11, 2012 Hopeful news for the future. Pat M. ---------- Forwarded message ---------- Date: Sat, Feb 11, 2012 at 4:03 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Drug quickly reverses Alzheimer's symptoms in mice<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/FnTIIG2W\ vGE/120209144005.htm?utm_source=feedburner & utm_medium=email> Posted: 09 Feb 2012 11:40 AM PST Neuroscientists have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The use of a drug appears to quickly reverse the pathological, cognitive and memory deficits caused by the onset of Alzheimer's in mice. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 1, 2012 Report Share Posted March 1, 2012 ---------- Forwarded message ---------- Date: Thu, Mar 1, 2012 at 4:05 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ - Reversing Alzheimer's gene 'blockade' can restore memory, other cognitive functions <#135cdb9274f706ff_1> - Reawakening neurons: Researchers find an epigenetic culprit in memory decline <#135cdb9274f706ff_2> - Blockade of learning and memory genes may occur early in Alzheimer's disease: Treatable in mice <#135cdb9274f706ff_3> Reversing Alzheimer's gene 'blockade' can restore memory, other cognitive functions<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/81O\ Ci82Dt-k/120229155534.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 12:55 PM PST Neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer's patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting that enzyme in mice, the researchers were able to reverse Alzheimer's symptoms. Reawakening neurons: Researchers find an epigenetic culprit in memory decline<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/TQork\ L9wg1E/120229142134.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 11:21 AM PST In a mouse model of Alzheimer's disease, memory problems stem from an overactive enzyme that shuts off genes related to neuron communication. Researchers genetically blocked the enzyme HDAC2, and 'reawakened' some of the neurons -- restoring the animals' cognitive function. Blockade of learning and memory genes may occur early in Alzheimer's disease: Treatable in mice<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/hZfyvPx2\ jak/120229142132.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 11:21 AM PST A repression of gene activity in the brain appears to be an early event affecting people with Alzheimer's disease, researchers have found. In mouse models of Alzheimer's disease, this epigenetic blockade and its effects on memory were treatable. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 1, 2012 Report Share Posted March 1, 2012 ---------- Forwarded message ---------- Date: Thu, Mar 1, 2012 at 4:05 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ - Reversing Alzheimer's gene 'blockade' can restore memory, other cognitive functions <#135cdb9274f706ff_1> - Reawakening neurons: Researchers find an epigenetic culprit in memory decline <#135cdb9274f706ff_2> - Blockade of learning and memory genes may occur early in Alzheimer's disease: Treatable in mice <#135cdb9274f706ff_3> Reversing Alzheimer's gene 'blockade' can restore memory, other cognitive functions<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/81O\ Ci82Dt-k/120229155534.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 12:55 PM PST Neuroscientists have shown that an enzyme overproduced in the brains of Alzheimer's patients creates a blockade that shuts off genes necessary to form new memories. Furthermore, by inhibiting that enzyme in mice, the researchers were able to reverse Alzheimer's symptoms. Reawakening neurons: Researchers find an epigenetic culprit in memory decline<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/TQork\ L9wg1E/120229142134.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 11:21 AM PST In a mouse model of Alzheimer's disease, memory problems stem from an overactive enzyme that shuts off genes related to neuron communication. Researchers genetically blocked the enzyme HDAC2, and 'reawakened' some of the neurons -- restoring the animals' cognitive function. Blockade of learning and memory genes may occur early in Alzheimer's disease: Treatable in mice<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/hZfyvPx2\ jak/120229142132.htm?utm_source=feedburner & utm_medium=email> Posted: 29 Feb 2012 11:21 AM PST A repression of gene activity in the brain appears to be an early event affecting people with Alzheimer's disease, researchers have found. In mouse models of Alzheimer's disease, this epigenetic blockade and its effects on memory were treatable. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted March 7, 2012 Report Share Posted March 7, 2012 Interesting articles. ---------- Forwarded message ---------- Date: Wed, Mar 7, 2012 at 4:08 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Specific antibodies halt Alzheimer's disease in mice<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/wTLFtSrr\ uaY/120306181155.htm?utm_source=feedburner & utm_medium=email> Posted: 06 Mar 2012 03:11 PM PST Antibodies that block the process of synapse disintegration in Alzheimer's disease have been identified, raising hopes for a treatment to combat early cognitive decline in the disease. Scientists pinpoint how vitamin D may help clear amyloid plaques found in Alzheimer's<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/U\ bBsvk8GuvM/120306131845.htm?utm_source=feedburner & utm_medium=email> Posted: 06 Mar 2012 10:18 AM PST Researchers have identified the intracellular mechanisms regulated by vitamin D3 that may help the body clear the brain of amyloid beta, the main component of plaques associated with Alzheimer's disease. The early findings show that vitamin D3 may activate key genes and cellular signaling networks to help stimulate the immune system to clear the amyloid-beta protein. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 8, 2012 Report Share Posted June 8, 2012 ---------- Forwarded message ---------- Date: Fri, Jun 8, 2012 at 4:06 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Alzheimer’s vaccine trial a success<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/k1_kt\ YbHNZs/120607092616.htm?utm_source=feedburner & utm_medium=email> Posted: 07 Jun 2012 06:26 AM PDT Medical researchers report, for the first time, the positive effects of an active vaccine against Alzheimer’s disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 8, 2012 Report Share Posted June 8, 2012 ---------- Forwarded message ---------- Date: Fri, Jun 8, 2012 at 4:06 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Alzheimer’s vaccine trial a success<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/k1_kt\ YbHNZs/120607092616.htm?utm_source=feedburner & utm_medium=email> Posted: 07 Jun 2012 06:26 AM PDT Medical researchers report, for the first time, the positive effects of an active vaccine against Alzheimer’s disease. The new vaccine, CAD106, can prove a breakthrough in the search for a cure for this seriously debilitating dementia disease. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 24, 2012 Report Share Posted June 24, 2012 ---------- Forwarded message ---------- Date: Sun, Jun 24, 2012 at 4:01 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ New approach to diagnosing and treating dementia<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/TaFY\ Vl_wJyE/120622163511.htm?utm_source=feedburner & utm_medium=email> Posted: 22 Jun 2012 01:35 PM PDT Some dementia patients show symptoms of a malfunctioning immune system. New research shows that immune reactions against the body's own nerve cells can be the cause of advanced dementia and an appropriate immune suppressive therapy can develop with significant effectiveness. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 24, 2012 Report Share Posted June 24, 2012 ---------- Forwarded message ---------- Date: Sun, Jun 24, 2012 at 4:01 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ New approach to diagnosing and treating dementia<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/TaFY\ Vl_wJyE/120622163511.htm?utm_source=feedburner & utm_medium=email> Posted: 22 Jun 2012 01:35 PM PDT Some dementia patients show symptoms of a malfunctioning immune system. New research shows that immune reactions against the body's own nerve cells can be the cause of advanced dementia and an appropriate immune suppressive therapy can develop with significant effectiveness. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 26, 2012 Report Share Posted June 26, 2012 ---------- Forwarded message ---------- Date: Tue, Jun 26, 2012 at 4:04 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Diabetes, poor glucose control associated with greater cognitive decline in older adults<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/z-qYLO\ 9Lj4Q/120618161724.htm?utm_source=feedburner & utm_medium=email> Posted: 18 Jun 2012 01:17 PM PDT Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a new report. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 26, 2012 Report Share Posted June 26, 2012 ---------- Forwarded message ---------- Date: Tue, Jun 26, 2012 at 4:04 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Diabetes, poor glucose control associated with greater cognitive decline in older adults<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/z-qYLO\ 9Lj4Q/120618161724.htm?utm_source=feedburner & utm_medium=email> Posted: 18 Jun 2012 01:17 PM PDT Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a new report. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 26, 2012 Report Share Posted June 26, 2012 ---------- Forwarded message ---------- Date: Tue, Jun 26, 2012 at 4:04 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Diabetes, poor glucose control associated with greater cognitive decline in older adults<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/z-qYLO\ 9Lj4Q/120618161724.htm?utm_source=feedburner & utm_medium=email> Posted: 18 Jun 2012 01:17 PM PDT Among well-functioning older adults without dementia, diabetes mellitus (DM) and poor glucose control among those with DM are associated with worse cognitive function and greater cognitive decline, according to a new report. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 28, 2012 Report Share Posted June 28, 2012 ---------- Forwarded message ---------- Date: Thu, Jun 28, 2012 at 4:07 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ - Post-anesthesia dementia, like Alzheimer's, looks micro-'tubular'<#1383258c121220be_1> - Alzheimer's spread through the brain mapped: Infects from neuron to neuron <#1383258c121220be_2> - New multitarget molecule designed with high potential in future treatments for Alzheimer's disease <#1383258c121220be_3> - Alzheimer’s disease spreads through linked nerve cells, brain imaging studies suggest <#1383258c121220be_4> Post-anesthesia dementia, like Alzheimer's, looks micro-'tubular'<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/\ ~3/QA02bgnCQTA/120627091617.htm?utm_source=feedburner & utm_medium=email> Posted: 27 Jun 2012 06:16 AM PDT Modern anesthesia is extremely safe. But as risks to heart, lungs and other organs have waned, another problem has emerged in the elderly: post-operative cognitive dysfunction. Mentally, some patients “just aren’t the same” for months or longer after surgery. Other factors play a role, but a small number of patients deteriorate mentally due to anesthesia per se. Those with Alzheimer’s disease suffer exacerbations, and those without the diagnosis may have it unmasked by anesthesia, suggesting some relationship. Alzheimer's spread through the brain mapped: Infects from neuron to neuron<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/ji-vZb\ HrPoQ/120626172728.htm?utm_source=feedburner & utm_medium=email> Posted: 26 Jun 2012 02:27 PM PDT The inexorable spread of Alzheimer's disease through the brain leaves dead neurons and forgotten thoughts in its wake. Researchers have now shown how toxic proteins are transferred from neuron to neuron. New multitarget molecule designed with high potential in future treatments for Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/bWTMF\ lBLGdA/120604093016.htm?utm_source=feedburner & utm_medium=email> Posted: 04 Jun 2012 06:30 AM PDT Researchers have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the ß-amyloid protein, involved in Alzheimer's disease. At the same time, ASS234 stimulates the cholinergic and monoaminergic transmission, key factors involved in the cognitive function. In addition, ASS234 is able to cross the blood–brain barrier with an elevated multipotent profile designed on basis of donepezil (Aricept®), one of the few effective drugs in palliative and symptomatic treatments of the disease. Alzheimer’s disease spreads through linked nerve cells, brain imaging studies suggest<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/V10y5\ 2KwR_o/120321105120.htm?utm_source=feedburner & utm_medium=email> Posted: 21 Mar 2012 07:51 AM PDT Alzheimer’s disease and other forms of dementia may spread within nerve networks in the brain by moving directly between connected neurons, instead of in other ways proposed by scientists, such as by propagating in all directions, according to new research. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 28, 2012 Report Share Posted June 28, 2012 ---------- Forwarded message ---------- Date: Thu, Jun 28, 2012 at 4:07 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ - Post-anesthesia dementia, like Alzheimer's, looks micro-'tubular'<#1383258c121220be_1> - Alzheimer's spread through the brain mapped: Infects from neuron to neuron <#1383258c121220be_2> - New multitarget molecule designed with high potential in future treatments for Alzheimer's disease <#1383258c121220be_3> - Alzheimer’s disease spreads through linked nerve cells, brain imaging studies suggest <#1383258c121220be_4> Post-anesthesia dementia, like Alzheimer's, looks micro-'tubular'<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/\ ~3/QA02bgnCQTA/120627091617.htm?utm_source=feedburner & utm_medium=email> Posted: 27 Jun 2012 06:16 AM PDT Modern anesthesia is extremely safe. But as risks to heart, lungs and other organs have waned, another problem has emerged in the elderly: post-operative cognitive dysfunction. Mentally, some patients “just aren’t the same” for months or longer after surgery. Other factors play a role, but a small number of patients deteriorate mentally due to anesthesia per se. Those with Alzheimer’s disease suffer exacerbations, and those without the diagnosis may have it unmasked by anesthesia, suggesting some relationship. Alzheimer's spread through the brain mapped: Infects from neuron to neuron<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/ji-vZb\ HrPoQ/120626172728.htm?utm_source=feedburner & utm_medium=email> Posted: 26 Jun 2012 02:27 PM PDT The inexorable spread of Alzheimer's disease through the brain leaves dead neurons and forgotten thoughts in its wake. Researchers have now shown how toxic proteins are transferred from neuron to neuron. New multitarget molecule designed with high potential in future treatments for Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/bWTMF\ lBLGdA/120604093016.htm?utm_source=feedburner & utm_medium=email> Posted: 04 Jun 2012 06:30 AM PDT Researchers have developed a multitarget molecule, ASS234, which according to the results of in vitro studies conducted, inhibits the aggregation of the ß-amyloid protein, involved in Alzheimer's disease. At the same time, ASS234 stimulates the cholinergic and monoaminergic transmission, key factors involved in the cognitive function. In addition, ASS234 is able to cross the blood–brain barrier with an elevated multipotent profile designed on basis of donepezil (Aricept®), one of the few effective drugs in palliative and symptomatic treatments of the disease. Alzheimer’s disease spreads through linked nerve cells, brain imaging studies suggest<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/V10y5\ 2KwR_o/120321105120.htm?utm_source=feedburner & utm_medium=email> Posted: 21 Mar 2012 07:51 AM PDT Alzheimer’s disease and other forms of dementia may spread within nerve networks in the brain by moving directly between connected neurons, instead of in other ways proposed by scientists, such as by propagating in all directions, according to new research. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 25, 2012 Report Share Posted July 25, 2012 ---------- Forwarded message ---------- Date: Wed, Jul 25, 2012 at 4:06 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ New drug could treat Alzheimer's, multiple sclerosis and brain injury<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/0XRifZ\ YY2os/120724171302.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:13 PM PDT A new class of drug shows early promise of being a one-size-fits-all therapy for Alzheimer's, Parkinson's, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. A new study reports when one of the new drugs is given to a mouse genetically engineered to develop Alzheimer's, it prevents the development of the disease when given during a newly identified therapeutic time window. How a single brain trauma may lead to Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/i8Vyh\ UF7OGM/120724171227.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:12 PM PDT A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer’s disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer’s. The new article identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme in the brain. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 25, 2012 Report Share Posted July 25, 2012 ---------- Forwarded message ---------- Date: Wed, Jul 25, 2012 at 4:06 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ New drug could treat Alzheimer's, multiple sclerosis and brain injury<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/0XRifZ\ YY2os/120724171302.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:13 PM PDT A new class of drug shows early promise of being a one-size-fits-all therapy for Alzheimer's, Parkinson's, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. A new study reports when one of the new drugs is given to a mouse genetically engineered to develop Alzheimer's, it prevents the development of the disease when given during a newly identified therapeutic time window. How a single brain trauma may lead to Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/i8Vyh\ UF7OGM/120724171227.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:12 PM PDT A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer’s disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer’s. The new article identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme in the brain. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 25, 2012 Report Share Posted July 25, 2012 ---------- Forwarded message ---------- Date: Wed, Jul 25, 2012 at 4:06 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ New drug could treat Alzheimer's, multiple sclerosis and brain injury<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/0XRifZ\ YY2os/120724171302.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:13 PM PDT A new class of drug shows early promise of being a one-size-fits-all therapy for Alzheimer's, Parkinson's, multiple sclerosis and traumatic brain injury by reducing inflammation in the brain. A new study reports when one of the new drugs is given to a mouse genetically engineered to develop Alzheimer's, it prevents the development of the disease when given during a newly identified therapeutic time window. How a single brain trauma may lead to Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/i8Vyh\ UF7OGM/120724171227.htm?utm_source=feedburner & utm_medium=email> Posted: 24 Jul 2012 02:12 PM PDT A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer’s disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer’s. The new article identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme in the brain. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted July 31, 2012 Report Share Posted July 31, 2012 ---------- Forwarded message ---------- Date: Tue, Jul 31, 2012 at 4:01 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Blocking the effects of amyloid b in Alzheimer's disease<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/Mr_Dg\ bycBS4/120730214110.htm?utm_source=feedburner & utm_medium=email> Posted: 30 Jul 2012 06:41 PM PDT During Alzheimer’s disease, 'plaques' of amyloid beta (Ab) and tau protein ‘tangles’ develop in the brain, leading to the death of brain cells and disruption of chemical signaling between neurons. This leads to loss of memory, mood changes, and difficulties with reasoning. New research has found that up-regulating the gene Hes1 largely counteracted the effects of Ab on neurons, including preventing cell death, and on GABAergic signaling. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 2, 2012 Report Share Posted August 2, 2012 ---------- Forwarded message ---------- Date: Thu, Aug 2, 2012 at 4:11 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Reviled substance involved in Alzheimer's can reverse paralysis in mice with multiple sclerosis<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/fex\ wjMFvCY8/120801143717.htm?utm_source=feedburner & utm_medium=email> Posted: 01 Aug 2012 11:37 AM PDT A molecule widely assailed as the chief culprit in Alzheimer's disease unexpectedly reverses paralysis and inflammation in several distinct animal models of a different disorder -- multiple sclerosis, researchers have found. Artificial butter flavoring ingredient linked to key Alzheimer's disease process<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/Up76E\ hIIi3U/120801132606.htm?utm_source=feedburner & utm_medium=email> Posted: 01 Aug 2012 10:26 AM PDT A new study raises concern about chronic exposure of workers in industry to a food flavoring ingredient used to produce the distinctive buttery flavor and aroma of microwave popcorn, margarines, snack foods, candy, baked goods, pet foods and other products. It found evidence that the ingredient, diacetyl, intensifies the damaging effects of an abnormal brain protein linked to Alzheimer's disease. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted August 2, 2012 Report Share Posted August 2, 2012 ---------- Forwarded message ---------- Date: Thu, Aug 2, 2012 at 4:11 AM Subject: ScienceDaily: Dementia News To: pmachkovich@... ** ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> <http://fusion.google.com/add?source=atgs & feedurl=http://feeds.feedburner.com/sc\ iencedaily/mind_brain/dementia> ------------------------------ Reviled substance involved in Alzheimer's can reverse paralysis in mice with multiple sclerosis<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/fex\ wjMFvCY8/120801143717.htm?utm_source=feedburner & utm_medium=email> Posted: 01 Aug 2012 11:37 AM PDT A molecule widely assailed as the chief culprit in Alzheimer's disease unexpectedly reverses paralysis and inflammation in several distinct animal models of a different disorder -- multiple sclerosis, researchers have found. Artificial butter flavoring ingredient linked to key Alzheimer's disease process<http://feedproxy.google.com/~r/sciencedaily/mind_brain/dementia/~3/Up76E\ hIIi3U/120801132606.htm?utm_source=feedburner & utm_medium=email> Posted: 01 Aug 2012 10:26 AM PDT A new study raises concern about chronic exposure of workers in industry to a food flavoring ingredient used to produce the distinctive buttery flavor and aroma of microwave popcorn, margarines, snack foods, candy, baked goods, pet foods and other products. It found evidence that the ingredient, diacetyl, intensifies the damaging effects of an abnormal brain protein linked to Alzheimer's disease. You are subscribed to email updates from ScienceDaily: Dementia News<http://www.sciencedaily.com/news/mind_brain/dementia/> To stop receiving these emails, you may unsubscribe now<http://feedburner.google.com/fb/a/mailunsubscribe?k=7j_lvZx1A_z6E4Auy01KZcc0\ 9B4> .. Email delivery powered by Google Google Inc., 20 West Kinzie, Chicago IL USA 60610 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.